Skip to main content
Premium Trial:

Request an Annual Quote

AB Sciex Expands in Singapore, Dubai

NEW YORK (GenomeWeb News) – Mass spectrometry technology firm AB Sciex said this week that it has recently expanded its manufacturing and operations in Asia and the Middle East with the opening of new facilities in Singapore and Dubai.

The Singapore facility is an R&D and manufacturing center, and is an extension of the firm's current facilities in the Marsiling district where it produces the AB Sciex 6500 series and TripleTOF series instruments. The company said today that the AB Sciex R&D Centre was created to bring R&D, product development, and manufacturing activities together, and it was expanded to make it possible to manufacture more of its products there.

AB Sciex also said it has transferred the manufacturing of Eksigent chromatography products from the US to Singapore.

On Tuesday, the firm said it also has opened a new regional office and technical support center in Dubai to support its customers in the Middle East region. The new Dubai center provides customer support before and after sale of products, and it provides training and application support through a stream of continuing education courses, AB Sciex said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.